Early Access — free while we kick the tires
EdgarHawk

Fox Jonathan C

Director

Director
1 filing analyzed · 1 company · Latest 2025-11-13

Companies

Company Buys Sells Direction
Edgewise Therapeutics, Inc. EWTX 1 0 Net buying

Activity

November 2025
medium
Buy
10,700 shares
$199,403
Significance 6/10

Director Fox buys 10,700 shares of EWTX at $18.64; stock now $20.42 (+43.9% from 90-day low), company unprofitable with $-40.7M net loss.

Director Jonathan C Fox purchased 10,700 shares at $18.64 on 2025-11-11, increasing his holdings by 82.3% to 23,702 shares total. This follows a prior buy at the same ticker in 2023 that delivered a 72.1% return over 90 days, and his cross-ticker track record shows 1 prior buy with 100.00% 90-day win rate. However, the company remains unprofitable with a $-40.7M net loss on the most recent full fiscal year, and the stock is currently 43.9% below its 52-week high of $36.38, though up 44.3% over the past 90 days. The timing and sizing of this purchase warrant attention given the insider's prior success at this ticker and the magnitude of the position increase, set against the company's ongoing losses and volatile price recovery.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access